Form 4: SI-BONE CEO Laura Francis Sells Shares Under 10b5-1 Trading Plan

SI-BONE, Inc. CEO Laura Francis sold 38,504 shares of common stock at a weighted-average price of $17.1766 under a pre-arranged 10b5-1 trading plan.

Summary

• On May 7, 2025, Laura Francis, CEO of SI-BONE, Inc., sold 38,504 shares of common stock.
• The sale was executed under a 10b5-1 trading plan.
• The shares were sold at a weighted-average price of $17.1766, with individual transactions ranging from $17.00 to $17.59.
• Following the transaction, Francis directly owns 506,761 shares and indirectly owns 302,958 shares through The David & Laura Francis Joint Rev Tr.
• This includes 442,987 shares issuable on the settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a routine disclosure of a pre-planned stock sale. There's no indication of positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information. The market reaction to such filings is usually minimal unless the size of the transaction is unusually large or signals a change in the executive's confidence in the company.

Key Dates

Keywords

SI-BONE, Laura Francis, insider trading, Form 4, stock sale, 10b5-1 plan, SIBN, CEO